1. Home
  2. ADVM vs AERT Comparison

ADVM vs AERT Comparison

Compare ADVM & AERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADVM
  • AERT
  • Stock Information
  • Founded
  • ADVM 2006
  • AERT 2012
  • Country
  • ADVM United States
  • AERT Singapore
  • Employees
  • ADVM N/A
  • AERT N/A
  • Industry
  • ADVM Biotechnology: Biological Products (No Diagnostic Substances)
  • AERT Professional Services
  • Sector
  • ADVM Health Care
  • AERT Consumer Discretionary
  • Exchange
  • ADVM Nasdaq
  • AERT Nasdaq
  • Market Cap
  • ADVM 47.4M
  • AERT 38.3M
  • IPO Year
  • ADVM 2014
  • AERT N/A
  • Fundamental
  • Price
  • ADVM $2.25
  • AERT $1.21
  • Analyst Decision
  • ADVM Strong Buy
  • AERT
  • Analyst Count
  • ADVM 5
  • AERT 0
  • Target Price
  • ADVM $26.40
  • AERT N/A
  • AVG Volume (30 Days)
  • ADVM 186.4K
  • AERT 277.6K
  • Earning Date
  • ADVM 08-11-2025
  • AERT 08-14-2025
  • Dividend Yield
  • ADVM N/A
  • AERT N/A
  • EPS Growth
  • ADVM N/A
  • AERT N/A
  • EPS
  • ADVM N/A
  • AERT 0.47
  • Revenue
  • ADVM $1,000,000.00
  • AERT $70,851,000.00
  • Revenue This Year
  • ADVM N/A
  • AERT N/A
  • Revenue Next Year
  • ADVM $18.82
  • AERT N/A
  • P/E Ratio
  • ADVM N/A
  • AERT $2.53
  • Revenue Growth
  • ADVM N/A
  • AERT 4.38
  • 52 Week Low
  • ADVM $1.78
  • AERT $0.46
  • 52 Week High
  • ADVM $10.14
  • AERT $2.93
  • Technical
  • Relative Strength Index (RSI)
  • ADVM 40.11
  • AERT 87.96
  • Support Level
  • ADVM $2.21
  • AERT $0.78
  • Resistance Level
  • ADVM $3.10
  • AERT $1.32
  • Average True Range (ATR)
  • ADVM 0.22
  • AERT 0.16
  • MACD
  • ADVM -0.00
  • AERT 0.07
  • Stochastic Oscillator
  • ADVM 4.49
  • AERT 82.73

About ADVM Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.

About AERT Aeries Technology Inc.

Aeries Technology Inc is a professional and management services partner offering a range of management consultancy services for private equity sponsors and their portfolio companies with engagement models that are designed to provide a mix of deep vertical specialty, functional expertise, and digital systems and solutions to scale, optimize and transform a client's business operations. It supports and drives its client's growth across the globe by providing a range of management consultancy services involving professional advisory services and operations management services to build and manage dedicated delivery centers in appropriate locations based on customer business needs.

Share on Social Networks: